SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/518B4993BEFB559E21E87D4A03CD442740F01600E5FB0444DBBC60C076CBAB5FDCDDEB38ED249FAA1B00EB010DEA421E>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/518B4993BEFB559E21E87D4A03CD442740F01600E5FB0444DBBC60C076CBAB5FDCDDEB38ED249FAA1B00EB010DEA421E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/518B4993BEFB559E21E87D4A03CD442740F01600E5FB0444DBBC60C076CBAB5FDCDDEB38ED249FAA1B00EB010DEA421E
http://www.w3.org/2000/01/rdf-schema#comment
"A multi-institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer."
xsd:string
http://purl.uniprot.org/uniprot/#_152BB7860D0B8CE8E8A20B4515E5EA5B9F3BE655A712027D39A339FA2DB34174BF9CF7B54C9CEE4482C22BC6E8CDC802
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/518B4993BEFB559E21E87D4A03CD442740F01600E5FB0444DBBC60C076CBAB5FDCDDEB38ED249FAA1B00EB010DEA421E
http://purl.uniprot.org/uniprot/O43915
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/518B4993BEFB559E21E87D4A03CD442740F01600E5FB0444DBBC60C076CBAB5FDCDDEB38ED249FAA1B00EB010DEA421E
http://purl.uniprot.org/uniprot/#_O43915-mappedCitation-32453456
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/518B4993BEFB559E21E87D4A03CD442740F01600E5FB0444DBBC60C076CBAB5FDCDDEB38ED249FAA1B00EB010DEA421E